Clinical Trials Details

S1400F LungMap - SUBSTUDY (Lung)

A Phase II Study of MEDI4736 (Durvalumab) Plus Tremelimumab as Therapy for Patients with Previously Treated Anti-PD-1/PD-L1 Resistant Stage IV Squamous Cell Lung Cancer (LungMAP Non-Match Substudy)

Clinical Trial Categories

  • Cancers and Other Neoplasms